Articles tagged "Immunosuppression"

2021 American Transplant Congress
Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?
J. Pagan¹, S. Anjan², Y. Natori³, A. Fernandez³, R. Zamora-Gonzalez², A. Mattiazzi¹, L. Mendez¹, G. Guerra¹
¹Nephrology, University of Miami, Miami, FL, ²Infectious Diseases, University of Miami, Miami, FL, ³Infectious Disease, University of Miami, Miami, FL
*Purpose: The COVID19 pandemic has affected kidney transplant recipients (KTR) with a wide spectrum of clinical severity. Up to this point, we have solely seen…
2021 American Transplant Congress
Remote Monitoring Using Mobile Phlebotomy and Donor-derived Cell-free DNA in Kidney Transplant Recipients During the Covid-19 Pandemic
N. Ali¹, J. Miles², V. Tatapudi¹, R. Montgomery¹
¹NYU Langone, New York, NY, ²Medical Science Liason, CareDx, Brisbane, CA
*Purpose: The rapid shift to telemedicine and remote monitoring of kidney transplant recipients (KTRs) during COVID-19 aimed to mitigate exposure risk for this vulnerable population.…
2021 American Transplant Congress
The Impact of High Kdpi on 1-year Post-transplant Graft Function and Survival in a Brazilian Cohort
H. Tedesco Silva Junior, R. Demarchi Foresto, M. Hazin, B. Cassão, A. Aquino, J. Taddeo, C. Rosso Felipe, L. Requião Moura, J. Medina
Núcleo de Ensino e Pesquisa, Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil
*Purpose: To evaluate the impact of High Kidney Donor Profile Index (KDPI) on 1-year post-transplant renal function and graft survival.*Methods: This retrospective cohort analyzed 3,059…
2021 American Transplant Congress
Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss
R. Valero¹, A. Aguilera¹, E. Rodrigo¹, D. San Segundo², M. Lopez-Hoyos², J. Ruiz¹
¹Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Spain, ²Inmunología, Hospital Universitario Marqués de Valdecilla, Santander, Spain
*Purpose: The number of patients awaiting for retransplantation has been progressively increasing. The presence of anti-HLA antibodies can significantly lengthen the waiting time, limiting the…
2021 American Transplant Congress
Symptoms on MTSOSD Questionnaire in Pancreas Transplantation Recipients
R. Kaur, S. R. Rizvi, B. H. Smith, C. Reid, S. K. McCrady-Spitzer, W. K. Kremers, P. G. Dean, A. Kukla, M. D. Stegall, Y. C. Kudva
Mayo Clinic, Rochester, MN
*Purpose: We used the Modified transplant symptom Occurrence and symptom distress scale (MTSOSD) to study side-effects of immunosuppression after Pancreas transplantation (PT) for patients with…
2021 American Transplant Congress
Outcomes of Kidney Transplantation in HIV Positive Highly Sensitized Recipients
S. Karhadkar, J. Panichella, H. Resweber, K. Nguyen, A. Di Carlo, S. Karhadkar
Temple University School of Medicine, Philadelphia, PA
*Purpose: Since the introduction of highly active antiretroviral therapy, HIV+ individuals are living longer, which has led to higher rates of end stage renal disease…
2021 American Transplant Congress
The Clinical Validation of a Dried Blood Spot Method for Simultaneous Tacrolimus and Creatinine Measurement
M. I. Francke¹, S. Bouarfa², B. van Domburg², D. van de Velde², M. E. Hellemons³, O. C. Manintveld⁴, S. M. Last-Koopmans⁵, M. B. Mulder², D. A. Hesselink¹, B. C. de Winter²
¹Internal medicine, nephrology and transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ²Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ³Pulmonary medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ⁴Cardiology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ⁵Hematology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
*Purpose: Monitoring tacrolimus concentrations and kidney function after transplantation is important to avoid tacrolimus under- and overexposure and its clinical consequences, including acute nephrotoxicity. Using…
2021 American Transplant Congress
Tacrolimus Shortage and the Rush to Convert: An Unexpected Burden on the System During the Covid-19 Pandemic?
N. Pilch, L. Johnson, M. Aldoughaim, N. Patel, F. Bartlett
Medical University of South Carolina, Charleston, SC
*Purpose: A national shortage of immediate release (IR) tacrolimus (FK) fully impacted our center in May 2020. The conversion process was immediately challenging during the…
2021 American Transplant Congress
Evaluation of Meningococcal Vaccine Response Among Solid Organ Transplant Recipients Receiving Eculizumab
R. Arora¹, C. Kane¹, K. Cunningham¹, M. Ison²
¹Pharmacy, Northwestern Memorial Hospital, Chicago, IL, ²Divisions of Infectious Diseases and Organ Transplantation, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Patients receiving eculizumab are at a 1,000-2,000-fold increased risk of invasive meningococcal infections. Therefore, the Advisory Committee for Immunization Practices recommends that these patients…
2021 American Transplant Congress
Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City
K. Khalil, S. Jonchhe, J. Stern, T. C. Lewis, N. Alnazari, B. Lonze, Z. Stewart Lewis, N. Ali
Transplant Institute, NYU Langone Health, New York, NY
*Purpose: As an early epicenter in the coronavirus pandemic, our center modified induction immunosuppression strategies for transplantation. We sought to determine if changes in induction…